Merck
MRK
$128.92
Share price
1.06%
Change (1 day)
8.90%
Change (1 year)
Categories
Merck (MRK) Fails to deliver data
Key failure to deliver metrics for Merck:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $1.29 M
- Last 3 months FTD volume: $6 M
- Last year FTD volume: $0.17 B
Failures to deliver for Merck (MRK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Merck (MRK) - since 2013
Volume in USD (price x number of shares), data since 2013Merck (MRK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $6.65 M | -98.35% |
| 2023 | $0.40 B | -21.9% |
| 2022 | $0.51 B | -20% |
| 2021 | $0.64 B | 402.3% |
| 2020 | $0.12 B | -31.62% |
| 2019 | $0.18 B | -56.08% |
| 2018 | $0.42 B | 535.89% |
| 2017 | $67.44 M | -64.21% |
| 2016 | $0.18 B | -29.02% |
| 2015 | $0.26 B | 2.16% |
| 2014 | $0.25 B | 138.9% |
| 2013 | $0.10 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $30.58 M | $84.43 M | 🇨🇭 Switzerland |
 Pfizer PFE | $16.08 M | $0.32 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $62.38 M | $0.13 B | 🇺🇸 USA |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $62.04 M | $0.18 B | 🇺🇸 USA |
 Sanofi SNY | $26.39 M | $50.57 M | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.24 M | $23.04 M | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $6.83 M | $36.36 M | 🇮🇱 Israel |